Assessing Bone Marrow Activity in Patients with Essential Thrombocythemia and Prefibrotic Myelofibrosis: Results of a Pilot Study of [18F]FLT PET
▪ Background Among several groups of clinicians and hematopathologists a conflict of opinion has been repeatedly expressed concerning the validity of bone marrow (BM) features characterizing myeloproliferative neoplasms (MPNs). In this regard, controversy is mainly focused on the distinction between...
Saved in:
Published in | Blood Vol. 138; no. Supplement 1; p. 4623 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
23.11.2021
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!